Enveric Biosciences Inc.

1.23
0.04 (3.36%)
At close: Apr 22, 2025, 3:59 PM
1.19
-3.53%
After-hours: Apr 22, 2025, 06:40 PM EDT

Enveric Biosciences Statistics

Share Statistics

Enveric Biosciences has 2.47M shares outstanding. The number of shares has increased by -75.33% in one year.

Shares Outstanding 2.47M
Shares Change (YoY) -75.33%
Shares Change (QoQ) -81.2%
Owned by Institutions (%) 12.4%
Shares Floating 2.32M
Failed to Deliver (FTD) Shares 2.4K
FTD / Avg. Volume 0.08%

Short Selling Information

The latest short interest is 179.52K, so 9.34% of the outstanding shares have been sold short.

Short Interest 179.52K
Short % of Shares Out 9.34%
Short % of Float 9.43%
Short Ratio (days to cover) 2.38

Valuation Ratios

The PE ratio is -0.28 and the forward PE ratio is -0.04. Enveric Biosciences's PEG ratio is 0.

PE Ratio -0.28
Forward PE -0.04
PS Ratio 0
Forward PS 0.1
PB Ratio 1.7
P/FCF Ratio -0.35
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Enveric Biosciences.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.

Current Ratio 1.84
Quick Ratio 1.84
Debt / Equity 0
Debt / EBITDA 0
Debt / FCF 0
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.91M
Employee Count 5
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -8.93K
Effective Tax Rate 0.09%

Stock Price Statistics

The stock price has increased by -90.87% in the last 52 weeks. The beta is 0.34, so Enveric Biosciences's price volatility has been higher than the market average.

Beta 0.34
52-Week Price Change -90.87%
50-Day Moving Average 1.59
200-Day Moving Average 5.25
Relative Strength Index (RSI) 36.42
Average Volume (20 Days) 2.83M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -9.63M
Net Income -9.57M
EBITDA -9.25M
EBIT n/a
Earnings Per Share (EPS) -19.04
Full Income Statement

Balance Sheet

The company has 2.24M in cash and 0 in debt, giving a net cash position of 2.24M.

Cash & Cash Equivalents 2.24M
Total Debt 0
Net Cash 2.24M
Retained Earnings -106.07M
Total Assets 3.08M
Working Capital 1.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.73M and capital expenditures 0, giving a free cash flow of -7.73M.

Operating Cash Flow -7.73M
Capital Expenditures 0
Free Cash Flow -7.73M
FCF Per Share -15.36
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ENVB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for ENVB is $10, which is 747.5% higher than the current price. The consensus rating is "Buy".

Price Target $10
Price Target Difference 747.5%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Jul 15, 2022. It was a backward split with a ratio of 1:50.

Last Split Date Jul 15, 2022
Split Type backward
Split Ratio 1:50

Scores

Altman Z-Score -56.84
Piotroski F-Score 3